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butoxide and pyrethroid-treated 
nets and indoor residual spraying 
for control of insecticide-resistant 
malaria mosquitoes (April 21, p 1577),2 
although sum marising accurately the 
trial’s findings, was less a commentary 
on its impli cations for future malaria 
control than a critique on the slow 
rate of progress in getting piperonyl 
butoxide synergist and other new long-
lasting insecticidal nets implemented 
to scale. The appeal by Killeen and 
Ranson, to roll out interventions not 
yet test ed against malaria outcomes 
rather than accelerating the evidence-
based process that our trial intended 
to inspire, runs the risk of reversing 
the process of evaluation or resuming 
the stalemate or free-for-all that arises 
between products when interventions 
are not fully assessed. What our 
study has shown is the importance 
of rigorous controlled trials to build 
evidence and guide strategy. What 
future trials of next generation long-
lasting insecticidal nets will require 
is a funding stream that will address 
the need for more timely evidence on 
effectiveness and durability. To guide 
malaria control strategy, an alliance or 
body of stakeholder representatives 
should be established that is com petent 
to make far-reaching public health 
decisions on the basis of that evidence. 
What would be helpful now is a review 
of why the stalemate on the use of 
piperonyl butoxide synergist long-
lasting insecticidal nets has existed for 
so long and how this trial can provide 
lessons for the future. 
The authors of the comment took 
the opportunity to express frus tration 
at the delays in decision making at 
WHO. With the benefit of the new 
evidence on piperonyl butoxide-
treated long-lasting insect icidal nets, 
it becomes easier to see why policy 
should change. But, until our trial, there 
was no definitive evidence that malaria 
control was being compromised by 
increasing insecticide resistance or that 
standard long-lasting insect icidal nets 
were starting to fail in some places. The 
global malaria burden had continued 
to air pollution. The development of 
successful control strategies to reduce 
air pollution requires planning at 
national, regional, and local levels and 
plausible inclusion of several external 
parameters, such as coarse particles. 
A more open-minded, flexible, and 
inclusive approach might be more 
effective to reduce the air pollution and 
adverse health effects at a regional level.
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study2 has shown that coarse particles 
(diameter >2·5 µm) are most common 
in many Indian cities. Our findings3,4 
from particulate matter collected from 
various Indian cities showed that coarse 
particles predominantly influence the 
total inflammatory responses induced 
by particulate matter. Therefore, a 
reduction in PM2·5 alone might not 
result in the proposed health benefits. 
Coarse particles will continue to 
dominate India’s metropolitan cities 
owing to an increase in vehicle usage, 
infrastructure shortages, and improper 
solid waste collection and transport. 
Indian cities that are below the rank of 
metropolitan cities are also facing high 
population growth and uncontrolled 
development. Because of the unpaved 
roads and resources shortages in these 
growing towns, coarse particle exposure 
will probably increase in the future. 
These coarse particles can deposit in 
distal airways and the upper respiratory 
tract. Inhalable fractions of particulate 
matter (diameter of about <15 µm) 
can deposit in the upper respiratory 
tract and might modulate carriage of 
bacteria in this area. Upper respiratory 
carriage of bacteria is a prerequisite for 
infection and is the primary reservoir for 
transmission in children and adults.5 
Population growth and overcrowding 
might increase the concentration of 
airborne biological particles in Indian 
cities;4 such increases would be caused 
by resuspension of road dust, improper 
handling and transport of sewage, 
increased vehicle usage, and solid waste 
in Indian cities. Our experiments4 have 
shown that airborne biological particles 
constitute a small, but notable, portion 
of the particulate matter and influence 
the total inflammatory response 
induced by particulate matter. Similar 
results were reported for particulate 
matter collected from other countries.6,7 
Our research8 shows that airborne 
biological particles are an important 
part of exposure in Indian households 
that burn biomass. In summary, the 
Commission makes an ambitious 
proposal to enhance public health 
through a reduction in global exposure 
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long-lasting insecticidal nets could 
slow the emergence of insecticide 
resistance. There is plenty of time to 
show that resistance selection can be 
slowed down, or even reversed, if the 
piperonyl butoxide-treated long-lasting 
insecticidal nets are scaled up fast 
enough. There are signs that the scale- 
up is already starting, following on 
from trial evidence. Another result that 
might have gone the other way was 
the effect of pirimiphos methyl indoor 
residual spraying when combined 
with standard long-lasting insecti-
cidal nets. Many trials of combinations 
of indoor residual spraying and long-
lasting insecticidal nets have not seen 
an added effect with other classes of 
indoor spraying insecticides.5 The long 
residual effect of this particular indoor 
residual spraying is remark able and 
unprecedented for any member of 
the organo phosphate or carbamate 
insecticide class and makes intermittent 
appli cation of indoor resid ual spraying a 
viable malaria control strategy. 
The appetite for running a small 
series of controlled trials on new classes 
of long-lasting insecticidal nets has 
recently grown, with the UNITAID 
Catalytic Fund stepping in to fill the 
evidence gap identified by WHO. 
Running in parallel to this series will 
be a restricted number of pilot rollouts 
in selected countries to gain more 
evidence from routine deployment, so 
that scale-up of the new long-lasting 
insecticidal nets is not delayed for 
longer than necessary.6 
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to decrease each year in parallel 
with increasing coverage of stand-
ard pyrethroid-treated long-lasting 
insecticidal nets. What our trial has 
shown is that resistance is now a sub-
stantial problem, standard pyrethroid-
treated long-lasting insecticidal nets 
are becoming less effective than 
before, and alternative long-lasting 
insecticidal nets containing synergist 
piperonyl butoxide will provide better 
protection and transmission control 
than standard long-lasting insecticidal 
nets. Before our trial and this year’s 
World Malaria Report,3 which showed 
that malaria levels had plateaued, 
there was not enough evidence to 
justify the switch. Killeen and Ranson 
say that trials should have been done 
earlier and, on this, we concur. They 
call for more trials. We agree with this, 
too. Before 2017, when WHO adopted 
new procedures for advising on trials 
and trial design,4 there had been 
little encouragement from WHO for 
comparative trials bet ween different 
classes of long-lasting insecticidal net 
products on disease outcomes, and 
no appetite for trials from product 
manufacturers and funding agencies. 
Killeen and Ranson say that our findings 
accord with the less rigorous phase 1 
and phase 2 entomological studies that 
preceded them. They do accord but, 
until our trial, there was no certainty that 
they would do so. That the outcomes 
did broadly accord is reassuring, and 
we can build on that. Before then, 
the evidence based on entomology 
alone was insufficient to shift policy to 
more expensive piperonyl butoxide-
treated long-lasting insect icidal nets. 
The trial did reveal several important 
findings that were not predicted. We 
expected an additive effect bet ween the 
piperonyl butoxide-treated long-lasting 
insecticidal nets and in door residual 
spraying interventions. That we did not 
see one was surprising, and useful, as 
it means there is no case for the more 
expensive com bined intervention, when 
one inter vention is sufficient. Killeen and 
Ranson say that we shall never know 
whether piperonyl butoxide-treated 
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Llibre JM, Hung C-C, Brinson C, et al. Efficacy, 
safety, and tolerability of dolutegravir-rilpivirine 
for the maintenance of virological suppression in 
adults with HIV-1: phase 3, randomised, 
non-inferiority SWORD-1 and SWORD-2 studies. 
Lancet 2018; 391: 839–49—In the legend of 
table 1 of this Article (published online first 
on Jan 5, 2018), the most commonly 
reported NNRTI at baseline should read 
“dolutegravir-rilpivirine, n=185 [36%]; CAR, 
n=189 [37%]”; the most commonly reported 
protease inhibitor at baseline should read 
“dolutegravir-rilpivirine, n=58 [11%]; CAR, 
n=40 [8%]”; and the most commonly 
reported INSTI at baseline should read 
“dolutegravir-rilpivirine, n=43 [8%]; CAR, 
n=44 [9%]”. The last sentence of the eighth 
paragraph in the Results section should read 
“having neuropsychiatric adverse events 
worse than grade 2”. In figure 3, for “Age 
<50 years”, “HIV-1 RNA <50 copies per mL 
(n/N)” should read “350/366” and the bar 
and diamond have been updated. In table 2, 
the dolutegravir-rilpivirine group should read 
“2 (<1%)” for “Neoplasms (benign, 
malignant, or unspecified)”. In figure 4, the 
“Total:HDL cholesterol” for the dolutegravir-
rilpivirine group’s baseline value should read 
“3·78”. The appendix of this Article has been 
updated. These corrections have been made 
to the online version as of Feb 1, 2018.
Sperber A. Health for migrants and Dominicans of 
Haitian descent. Lancet 2018; 391: 2093–94—
In this World Report, the following phrase 
should have read: “…the 2010 earthquake that 
killed more than 300 000 and displaced 
1·5 million people”. This correction has been 
made to the online version as of May 31, 2018.
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